Transmembrane Stem Cell Factor Protein Therapeutics EnhanceRevascularization in Ischemia without Mast Cell Activation
E. Takematsu, J. Auster, P.-C. Chen, S. Srinath, S. Canga, A. Singh, M. Majid, M. Sherman, A. Dunn, A. Graham, P. Martin, A. Baker
This study develops tmSCF-based therapeutics that enhance revascularization in ischemia without activating mast cells, using proteoliposomes and lipid nanodiscs as delivery systems.
bioRxiv · Apr 6, 2020Bioengineering